Recovery of vitamin D levels by cholecalciferol supplementation on obese rats
DOI:
https://doi.org/10.21927/ijnd.2024.1(1).40-48Kata Kunci:
cholecalciferol, obesitas, vitamin D, obesityAbstrak
ABSTRAK
Latar Belakang: Obesitas disebabkan oleh penumpukan lemak dalam tubuh karena faktor biologis, psikososial, dan perilaku. Prevalensi obesitas mencapai 42,24% di Amerika Serikat, sementara overweight dan obesitas mencapai 59% di Eropa. Obesitas dapat menyebabkan defisiensi vitamin D melalui berbagai mekanisme.
Tujuan: Untuk mengatahui pengaruh pemberian suplementasi cholecalciferol terhadap kadar 25(OH)D pada tikus obesitas.
Metode: Dalam penelitian ini, kami melakukan penelitian  true experiment with.        pre-post test control group design. Penelitian ini menganalisis 3 kelompok tikus galur Sprague Dawley jantan yang diinduksi dengan diet tinggi lemak tinggi fruktosa (HFHF)  menjadi tikus obesitas. Masing-masing kelompok mendapatkan cholecalciferol sebanyak 2,500 IU/200gr/hari pada kelompok P1, 5,000IU/200gr/hari pada kelompok P2, dan 10,000 IU/200gr/hari pada kelompok P3 selama 8 minggu. Tikus kemudian dianalisis kadar serum 25(OH)D sebelum dan sesudah perlakuan.
Hasil: Suplementasi cholecalciferol secara signifikan meningkatkan kadar vitamin D pada setiap kelompok intervensi yang diberikan cholecalciferol. Rerata kadar 25(OH)D kelompok P1,P2, dan P3 sebelum perlakuan  berturut-turut adalah 29,43±0,83 ng/mL, 28,61±1,57 ng/mL, dan 28,86±1,46 ng/mL. Rerata kadar 25(OH)D setelah suplementasi cholecalciferol untuk kelompok P1,P2, dan P3 berturut-turut adalah 74,27±0,77 ng/mL, 100,30±1,48 ng/mL, dan 126,73±2,30 ng/mL. Ada perbedaan yang signifikan antara nilai 25(OH)D sebelum dan sesudah perlakuan  pada ketiga kelompok intervensi dengan nilai (p<0,05).
Kesimpulan: Pemberian cholecalciferol mampu meningkatkan kadar 25(OH)D pada tikus jantan yang diinduksi obesitas.
Â
KATA KUNCI: cholecalciferol; obesitas; vitamin D
Â
ABSTRACTÂ
Background: Obesity is caused by the accumulation of fat in the body due to biological, psychosocial and behavioral factors. The prevalence of obesity reaches 42.24% in the United States, while overweight and obesity reaches 59% in Europe. Obesity can cause vitamin D deficiency through various mechanisms.
Objectives: To determine the effect of cholecalciferol supplementation on 25(OH)D levels in obese mice.
Methods: In this research, we conducted a true experiment research with pre-post test control group design. This study analyzed 3 groups of male Sprague Dawley rats that were induced by a high-fat, high-fructose (HFHF) diet to become obese rats. Each group received 2,500 IU/200gr/day of cholecalciferol in group P1, 5,000IU/200gr/day in group P2, and 10,000 IU/200gr/day in group P3 for 8 weeks. The mice were then analyzed for serum 25(OH)D levels before and after treatment.
Results: Cholecalciferol supplementation significantly increased vitamin D levels in each intervention group given cholecalciferol. The mean 25(OH)D levels in groups P1, P2, and P3 before treatment were 29.43 ± 0.83 ng/mL, 28.61 ± 1.57 ng/mL, and 28.86 ± 1.46, respectively. ng/mL. The mean 25(OH)D levels after cholecalciferol supplementation for groups P1, P2, and P3 were 74.27±0.77 ng/mL, 100.30±1.48 ng/mL, and 126.73±2 respectively. .30 ng/mL. There was a significant difference between the 25(OH)D values before and after treatment in the three intervention groups with values (p<0.05).
Conclusion: Administration of cholecalciferol can increase 25(OH)D levels in male mice that are induced by obesity.
Â
KEYWORDS: cholecalciferol, vitamin D, obesity
Referensi
Purnell JQ. Definitions, Classification, and Epidemiology of Obesity. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editor. South Dartmouth (MA); 2000.
Ahmad S, Imam K syed. Obesity: A Practical Guide. Ahmad S, Imam K syed, editor. Elsevier; 2016.
Oktavia SN. Hubungan Kadar Vitamin D Dalam Darah Dengan Kejadian Obesitas Pada Siswa Sma Pembangunan Padang. J Akad Baiturrahim Jambi. 2019;8(1):1.
Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Vol. 133, Metabolism: clinical and experimental. United States; 2022. hal. 155217.
Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics [Internet]. Vol. 12, Frontiers in Endocrinology . 2021. Tersedia pada: https://www.frontiersin.org/articles/10.3389/fendo.2021.706978
Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riset Kesehatan Dasar. Kementeri Kesehat RI. 2018;1–582.
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. Juni 2016;22(7 Suppl):s176-85.
Avtanski D, Garcia A, Liao E. Vitamin D and Obesity. In: Liao E, editor. Extraskeletal Effects of Vitamin D Contemporary Endocrinology [Internet]. Humana Press; 2018. Tersedia pada: https://doi.org/10.1007/978-3-319-73742-3_9
Lapik IA, Galchenko A V, Gapparova KM. Micronutrient status in obese patients: A narrative review. Obes Med [Internet]. 2020;18:100224. Tersedia pada: https://www.sciencedirect.com/science/article/pii/S2451847620300440
Vranić L, Mikolašević I, Milić S. Vitamin D Deficiency: Consequence or Cause of Obesity? Medicina (Kaunas). Agustus 2019;55(9).
Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. Desember 2017;24(6):389–94.
Louisa M, Paramita. Berbagai Manfaat Vitamin D. Dep Farmakol dan Ter Fak Kedokt Univ Indones Jakarta, Indones. 2017;44(10):736–40.
Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. Februari 2022;18(2):96–110.
Khosravi ZS, Kafeshani M, Tavasoli P, Zadeh AH, Entezari MH. Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study. Int J Prev Med. 2018;9:63.
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. Juni 2017;18(2):153–65.
Hanafy AS, Elkatawy HA. Beneficial Effects of Vitamin D on Insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory Obesity. Clin Diabetes. Juli 2018;36(3):217–25.
Nair R, Maseeh A. Vitamin D: The “sunshine†vitamin. J Pharmacol Pharmacother. April 2012;3(2):118–26.
Karampela I, Sakelliou A, Vallianou N, Christodoulatos GS, Magkos F, Dalamaga M. Vitamin D and Obesity: Current Evidence and Controversies. Curr Obes Rep. 1 Juni 2021;10.
Pereira-Santos M, Costa PRF, Assis AMO, Santos CAST, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev an Off J Int Assoc Study Obes. April 2015;16(4):341–9.
Lotfi-Dizaji L, Mahboob S, Aliashrafi S, Vaghef-Mehrabany E, Ebrahimi-Mameghani M, Morovati A. Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial. Clin Endocrinol (Oxf). Januari 2019;90(1):94–101.
Sekel NM, Gallo S, Fields J, Jagim AR, Wagner T, Jones MT. The Effects of Cholecalciferol Supplementation on Vitamin D Status Among a Diverse Population of Collegiate Basketball Athletes: A Quasi-Experimental Trial. Nutrients. Januari 2020;12(2).
Žmitek K, Hribar M, Hristov H, Pravst I. Efficiency of Vitamin D Supplementation in Healthy Adults is Associated with Body Mass Index and Baseline Serum 25-Hydroxyvitamin D Level. Nutrients. April 2020;12(5).
Quraishi SA, De Pascale G, Needleman JS, Nakazawa H, Kaneki M, Bajwa EK, et al. Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit Care Med. September 2015;43(9):1928–37.
Sosa HenrÃquez M, Gómez de Tejada Romero MJ. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency. Nutrients. Mei 2020;12(6).
Ramasamy I. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. Clin Biochem Rev. Desember 2020;41(3):103–26.
Karonova T, Grineva E, Belyaeva O, Bystrova A, Jude EB, Andreeva A, et al. Relationship Between Vitamin D Status and Vitamin D Receptor Gene Polymorphisms With Markers of Metabolic Syndrome Among Adults. Front Endocrinol (Lausanne). 2018;9:448.
Carrelli A, Bucovsky M, Horst R, Cremers S, Zhang C, Bessler M, et al. Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women. J bone Miner Res Off J Am Soc Bone Miner Res. Februari 2017;32(2):237–42.
Surdu AM, Pînzariu O, Ciobanu D-M, Negru A-G, Căinap S-S, Lazea C, et al. Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Vol. 9, Biomedicines. 2021.
Yarparvar A, Elmadfa I, Djazayery A, Abdollahi Z, Salehi F. The Association of Vitamin D Status with Lipid Profile and Inflammation Biomarkers in Healthy Adolescents. Nutrients. Februari 2020;12(2).
Unduhan
File Tambahan
Diterbitkan
Terbitan
Bagian
Lisensi
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.  that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Â
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Â
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Â
IJND by http://ejournal.almaata.ac.id/index.php/IJND is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.Â
